232 related articles for article (PubMed ID: 33032056)
1. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study.
Rafiee F; Tarjoman T; Moghadasi AN; Sahraian MA; Azimi A; Rezaeimanesh N; Eskandarieh S
Mult Scler Relat Disord; 2020 Nov; 46():102544. PubMed ID: 33032056
[TBL] [Abstract][Full Text] [Related]
2. Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study.
Alsharie AM; Rafiee F; Rezaeimanesh N; Moghadasi AN; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2021 Jun; 51():102937. PubMed ID: 33857898
[TBL] [Abstract][Full Text] [Related]
3. Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Azimi AR; Moghadasi AN; Asgari N; Sahraian MA
Acta Neurol Belg; 2018 Jun; 118(2):277-287. PubMed ID: 29500680
[TBL] [Abstract][Full Text] [Related]
4. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
5. Neuromyelitis optica spectrum disorders in Iran.
Eskandarieh S; Nedjat S; Azimi AR; Moghadasi AN; Sahraian MA
Mult Scler Relat Disord; 2017 Nov; 18():209-212. PubMed ID: 29141812
[TBL] [Abstract][Full Text] [Related]
6. The association between dietary sugar intake and neuromyelitis optica spectrum disorder: A case-control study.
Rezaeimanesh N; Razeghi Jahromi S; Ghorbani Z; Beladi Moghadam N; Hekmatdoost A; Naser Moghadasi A; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2019 Jun; 31():112-117. PubMed ID: 30978652
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica spectrum disorder and menstruation.
Badihian S; Manouchehri N; Mirmosayyeb O; Ashtari F; Shaygannejad V
Rev Neurol (Paris); 2018 Dec; 174(10):716-721. PubMed ID: 30049560
[TBL] [Abstract][Full Text] [Related]
8. IRAK1 polymorphisms are associated with susceptibility to neuromyelitis optica spectrum disorder.
Shi Z; Chen H; Du Q; Zhang Y; Zhang Q; Qiu Y; Zhao Z; Wang J; Yang M; Zhou H
Mult Scler Relat Disord; 2020 Jan; 37():101438. PubMed ID: 32173002
[TBL] [Abstract][Full Text] [Related]
9. STAT4 Polymorphisms are Associated with Neuromyelitis Optica Spectrum Disorders.
Shi Z; Zhang Q; Chen H; Lian Z; Liu J; Feng H; Miao X; Du Q; Zhou H
Neuromolecular Med; 2017 Dec; 19(4):493-500. PubMed ID: 28852993
[TBL] [Abstract][Full Text] [Related]
10. Stress-full life events and multiple sclerosis: A population-based incident case-control study.
Abdollahpour I; Nedjat S; Mansournia MA; Eckert S; Weinstock-Guttman B
Mult Scler Relat Disord; 2018 Nov; 26():168-172. PubMed ID: 30268037
[TBL] [Abstract][Full Text] [Related]
11. Association Analysis Between HLA-DQA1 Loci and Neuromyelitis Optica Spectrum Disorder in a Han Chinese Population.
Zhou L; He Z; Zhu L; Zhu JJ; Zhu JH; Pan J
Neurologist; 2022 Jul; 27(4):164-167. PubMed ID: 34873111
[TBL] [Abstract][Full Text] [Related]
12. BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder.
Yin BW; Li B; Mehmood A; Yuan C; Song S; Guo RY; Zhang L; Ma T; Guo L
CNS Neurosci Ther; 2021 Dec; 27(12):1549-1560. PubMed ID: 34637583
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
[TBL] [Abstract][Full Text] [Related]
14. Bone health in neuromyelitis optica: Bone mineral density and fractures.
Kwon YN; Im SY; Park YS; Ahn SH; Seo J; Kim SB; Yoon SS; Waters P; Choi HJ; Kong SH; Sung JJ; Kim SM; Park KS
Mult Scler Relat Disord; 2020 Jul; 42():102080. PubMed ID: 32497999
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controls.
Barzegar M; Sadeghi Bahmani D; Nehzat N; Kiani M; Hashemi N; Mirmosayyeb O; Brand S; Shaygannejad V
Mult Scler Relat Disord; 2019 Jul; 32():81-87. PubMed ID: 31063950
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
Fernández VC; Alonso N; Melamud L; Villa AM
Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of types of psychological disorders in patients with neuromyelitis optica spectrum disorder (NMOSD).
Ebadi Z; Saeedi R; Hashemi SN; Gheini MR; Sahraian MA; Naser Moghadasi A
Mult Scler Relat Disord; 2020 Jul; 42():102128. PubMed ID: 32388460
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D status and the risk of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis.
Liu S; Tan B; Zhou J; Xiao L; Li M; Yin J
J Clin Neurosci; 2024 Jan; 119():185-192. PubMed ID: 38113581
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for venous thromboembolism during an acute attack in patients with neuromyelitis optica spectrum disorders.
Pan J; Zhu R; Lin J; Li X; Xia J
Mult Scler Relat Disord; 2022 Feb; 58():103513. PubMed ID: 35038646
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.
Huang W; ZhangBao J; Chang X; Wang L; Zhao C; Lu J; Wang M; Ding X; Xu Y; Zhou L; Li D; Behne MK; Behne JM; Yeaman MR; Katz E; Lu C; Quan C;
Mult Scler Relat Disord; 2020 Nov; 46():102542. PubMed ID: 33296965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
